Publications
Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD
Use: Start with an overview of all publications. Use tag links to list selected documents or to list an entire category, e.g. Original Work, Books, Book Chapters, Reviews. If you know what you are looking for, enter this term in the search field.
- [o.284] Analysis of disease activity categories in chronic spontaneous/idiopathic urticaria (2)
- [o.437] Analysis of genetic impact on smell impairment in patients with hereditary angioedema type 1 and 2 (0)
- [o.571] Analysis of questionnaire survey to determine worldwide trends in prescriptions of biologics for the treatment of unresponsive chronic urticaria (0)
- [o.171] Anaphylaxis caused by Mosquito allergy in systemic mastocytosis (0)
- [o.394] Anaphylaxis to mepolizumab and omalizumab in a single patient – is polysorbate the culprit? (2)
- [o.365] Angioedema Activity Score (AAS): A Valid and Reliable Tool to Use in Asian Patients (4)
- [o.350] Angioedema frequently occurs in cholinergic urticaria (4)
- [o.318] Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: analyses from ASSURE-CSU (2)
- [o.245] Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies (0)
- [o.364] Angioedema quality of life questionnaire (AE-QoL) - interpretability and sensitivity to change (6)
- [o.553] Anti-IL-23 treatment with tildrakizumab can be effective in omalizumab-refractory chronic spontaneous urticaria – a case series (0)
- [o.104] Anti-Immunoglobulin E Treatment of Patients with Recalcitrant Physical Urticaria (3)
- [o.543] Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria (5)
- [o.490] Anti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer study (0)
- [o.248] Anti-pruritic effect of sertaconazole 2% cream in atopic dermatitis subjects: a prospective, randomized, double-blind, vehicle-controlled, multi-centre clinical trial of efficacy, safety and local tolerability (0)
- [o.250] Antihistamine updosing reduces disease activity in patients with difficult-to-treat cholinergic urticaria (3)
- [o.400] Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study (4)
- [o.101] Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy (0)
- [o.351] Antihistamine‐resistant chronic spontaneous urticaria: 1‐year data from the AWARE study (0)
- [o.374] Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU (2)
(Last update: 09.2024)
Number of original publications in peer-reviewed journals: | 626 |
Number of reviews in peer-reviewed journals: | 221 |
Number of publications (original work and reviews) in peer-reviewed journals: | 847 |
Cumulative IF for original publications in peer-reviewed journals: | 4432.59 |
Cumulative IF for reviews in peer-reviewed journals: | 1648.22 |
Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 6080.81 |
Total number of citations: 38,608, h-index: 99 (Web of Science September 2024) | 38,608 |
Download-Information
To be able to download the offered contents, you have to login. If you do not know the login, please write me your request.